ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) JPX

2,059.00

+10(+0.49%)

Updated at December 25 02:30PM

Currency In JPY

Valuation

Market Cap65.31B
Enterprise Value65.61B
P/E Ratio12.2
PEG Ratio-2.02
Price/Sales Ratio0.85
Price/Book Ratio0.87
Enterprise/Revenue0.93
Enterprise/EBITDA8.92

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.07
Operating Margin0.07

Management Effectiveness

Return On Assets0.04
Return On Equity0.07

Income Statement

Revenue64.14B
Revenue/Share2,420.53
Gross Profit31.34B
EBITDA8.49B
Net Income5.1B
Diluted EPS179.94

Balance Sheet

Total Cash7.45B
Total Cash/Share262.41
Total Debt12.63B
Total Debt/Equity0.19
Current Ratio2.47
Book Value Per Share2,557.62

Price History

52-Week Change-0.77
52-Week High2,942
52-Week Low1,825
Moving Average 50 Days2,051.18
Moving Average 200 Days2,278.46

Statistics

Average Volume59,213
Shares Outstanding28.37M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate52
Trailing Annual Dividend Yield2.54
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A